The present invention relates to novel compounds, particularly derivatives of boroarginine, boroornithine and borolysine that selectively modulate, regulate, and/or inhibit enteropeptidase. The invention also relates to compositions, particularly pharmaceutical compositions, as well as methods to treat excess weight, obesity and diseases associated with an abnormal fat metabolism.
本发明涉及新型化合物,特别是
硼精
氨酸衍
生物、
硼鸟氨酸衍
生物和
硼赖
氨酸衍
生物,它们能够选择性地调节、调控和/或抑制
肠肽酶。本发明还涉及组合物,特别是制药组合物,以及治疗过度体重、肥胖和与异常脂肪代谢相关的疾病的方法。